查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1381039

消化性溃疡治疗药物市场：依消化性溃疡类型、药物类型、配销通路- 全球预测 2023-2030

Peptic Ulcer Drugs Market by Peptic Ulcer Type (Duodenal Ulcer, Gastric Ulcer), Drug Type (Cytoprotective Agents, H2 Blockers, Proton Pump Inhibitors (PPIs)), Distribution Channel - Global Forecast 2023-2030
出版日期: | 出版商: 360iResearch | 英文 194 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

消化性溃疡药物市场预计将从 2022 年的 43 亿美元增加到 2030 年的 64.3 亿美元，预测期内年复合成长率为 5.15%。

全球消化性溃疡药物市场

主要市场统计
市场金额：基准年 [2022] 43亿美元
预计市场金额[2023] 45.1亿美元
预计市场金额[2030] 64.3亿美元
年复合成长率（%） 5.15%
消化性溃疡治疗药物市场-IMG1

FPNV定位矩阵

FPNV定位矩阵是评估消化性溃疡药物市场的重要工具。透过分析与业务策略和产品满意度相关的关键指标来全面评估供应商。这使得使用者能够根据自己的具体资讯做出明智的决策。进阶分析将供应商分为四个像限，每个象限都有不同程度的成功：前沿 (F)、探路者 (P)、利基 (N) 和重要 (V)。这个富有洞察力的框架使决策者能够充满信心地驾驭市场。

市场占有率分析

市场占有率分析为供应商的市场形势提供了宝贵的见解。评估对整体收益、客户群和其他关键指标的影响可以全面了解公司的业绩及其面临的竞争环境。该分析还揭示了研究期间的竞争水平，例如市场占有率增长、碎片化、主导地位和行业整合。

该报告对以下几个方面提供了宝贵的见解：

1.市场渗透：提供有关市场动态和主要企业产品的全面资讯。

2. 市场开拓：详细分析新兴和成熟细分市场的渗透情况，以突显利润丰厚的商机。

3. 市场多元化：有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4.竞争评估与资讯：对主要企业的市场占有率、策略、产品、认证、法规状况、专利状况、製造能力等进行综合评估。

5. 产品开发与创新：对未来技术、研发活动和突破性产品开发的智慧洞察。

本报告解决了以下关键问题：

1.消化性溃疡治疗药物市场的市场规模与预测是多少？

2.消化性溃疡药物市场中哪些产品、细分市场、应用和领域具有最高的投资潜力？

3.消化性溃疡治疗药物市场竞争策略的窗口是什么？

4.消化性溃疡治疗药物市场的最新技术趋势和法律规范是什么？

5.消化性溃疡治疗药物市场主要厂商的市场占有率是多少？

6. 进入消化性溃疡药物市场的合适型态和策略手段是什么？

目录

第1章前言

第2章调查方法

第3章执行摘要

第4章市场概况

第5章市场洞察

  • 市场动态
    • 促进因素
      • 随着老年人口的增加，消化性溃疡的盛行率很高
      • 提高对消化性溃疡的认识和诊断技术的进步
      • 越来越重视以病人为中心的照护和个体化消化性溃疡治疗
    • 抑制因素
      • 消化性溃疡药物价格高
    • 机会
      • 介绍更新、更有效的消化性溃疡治疗方法
      • 扩大远端医疗和电子商务平台的采用
    • 任务
      • 与消化性溃疡药物相关的不良反应
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第6章消化性溃疡治疗药物市场（依消化性溃疡类型）

  • 十二指肠溃疡
  • 胃溃疡

第7章消化性溃疡治疗药物市场（依药物类型）

  • 细胞保护剂
  • H2阻断剂
  • 质子帮浦抑制剂 (PPI)

第8章消化性溃疡治疗药物市场：按配销通路

  • 离线
    • 医院
    • 零售药房
  • 在线的

第9章美洲消化性溃疡治疗市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第10章亚太消化性溃疡药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第11章欧洲、中东和非洲消化性溃疡治疗市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第12章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第13章竞争产品组合

  • 主要公司简介
    • Abbott Laboratories
    • AbbVie Inc.
    • AstraZeneca PLC
    • Boehringer Ingelheim International GmbH
    • Cadila Healthcare Ltd.
    • Century Pharmaceuticals Ltd.
    • Daewoong Pharmaceutical Co. LTD.
    • Dr. Reddy's Laboratories Ltd
    • Eisai Co. Ltd.
    • F. Hoffmann-La Roche Ltd.
    • GlaxoSmithKline PLC
    • Hikma Pharmaceuticals PLC
    • Medopharm Pvt Ltd
    • Merck KGaA
    • Mylan NV
    • Novartis AG
    • Pfizer Inc.
    • Pharmanova India Drugs Pvt. Ltd.
    • Redhill Biopharma Ltd
    • Rosemont Pharmaceuticals Limited
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceutical Industries Ltd.
    • Ulcerex Pharma
    • USAntibiotics
    • Yuhan Corporation
  • 主要产品系列

第14章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-2A0283E256D2

The Peptic Ulcer Drugs Market is projected to reach USD 6.43 billion by 2030 from USD 4.30 billion in 2022, at a CAGR of 5.15% during the forecast period.

Global Peptic Ulcer Drugs Market

KEY MARKET STATISTICS
Base Year Value [2022] USD 4.30 billion
Estimated Year Value [2023] USD 4.51 billion
Forecast Year Value [2030] USD 6.43 billion
CAGR (%) 5.15%
Peptic Ulcer Drugs Market - IMG1

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Peptic Ulcer Drugs Market.

Based on Peptic Ulcer Type, market is studied across Duodenal Ulcer and Gastric Ulcer. The Gastric Ulcer is projected to witness significant market share during forecast period.

Based on Drug Type, market is studied across Cytoprotective Agents, H2 Blockers, and Proton Pump Inhibitors (PPIs). The Proton Pump Inhibitors (PPIs) is projected to witness significant market share during forecast period.

Based on Distribution Channel, market is studied across Offline and Online. The Offline is further studied across Hospitals and Retail Pharmacies. The Online is projected to witness significant market share during forecast period.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Asia-Pacific is projected to witness significant market share during forecast period.

Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Peptic Ulcer Drugs Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Peptic Ulcer Drugs Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Peptic Ulcer Drugs Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AbbVie Inc., AstraZeneca PLC, Boehringer Ingelheim International GmbH, Cadila Healthcare Ltd., Century Pharmaceuticals Ltd., Daewoong Pharmaceutical Co. LTD., Dr. Reddy's Laboratories Ltd, Eisai Co. Ltd., F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Hikma Pharmaceuticals PLC, Medopharm Pvt Ltd, Merck KGaA, Mylan N.V., Novartis AG, Pfizer Inc., Pharmanova India Drugs Pvt. Ltd., Redhill Biopharma Ltd, Rosemont Pharmaceuticals Limited, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., Ulcerex Pharma, USAntibiotics, and Yuhan Corporation.

The report offers valuable insights on the following aspects:

1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.

2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.

3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.

4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.

5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast for the Peptic Ulcer Drugs Market?

2. Which products, segments, applications, and areas hold the highest investment potential in the Peptic Ulcer Drugs Market?

3. What is the competitive strategic window for identifying opportunities in the Peptic Ulcer Drugs Market?

4. What are the latest technology trends and regulatory frameworks in the Peptic Ulcer Drugs Market?

5. What is the market share of the leading vendors in the Peptic Ulcer Drugs Market?

6. Which modes and strategic moves are suitable for entering the Peptic Ulcer Drugs Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Peptic Ulcer Drugs Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of peptic ulcers with expanding geriatric population
      • 5.1.1.2. Growing awareness about peptic ulcers and advancements in diagnostic techniques
      • 5.1.1.3. Increasing emphasis on patient-centric care and personalized peptic ulcer treatment
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of peptic ulcer drugs
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of newer and effective peptic ulcer drugs
      • 5.1.3.2. Growing adoption of telemedicine and e-commerce platforms
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with peptic ulcer drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Peptic Ulcer Drugs Market, by Peptic Ulcer Type

  • 6.1. Introduction
  • 6.2. Duodenal Ulcer
  • 6.3. Gastric Ulcer

7. Peptic Ulcer Drugs Market, by Drug Type

  • 7.1. Introduction
  • 7.2. Cytoprotective Agents
  • 7.3. H2 Blockers
  • 7.4. Proton Pump Inhibitors (PPIs)

8. Peptic Ulcer Drugs Market, by Distribution Channel

  • 8.1. Introduction
  • 8.2. Offline
    • 8.3.1. Hospitals
    • 8.3.2. Retail Pharmacies
  • 8.3. Online

9. Americas Peptic Ulcer Drugs Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Peptic Ulcer Drugs Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Peptic Ulcer Drugs Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. FPNV Positioning Matrix
  • 12.2. Market Share Analysis, By Key Player
  • 12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

  • 13.1. Key Company Profiles
    • 13.1.1. Abbott Laboratories
    • 13.1.2. AbbVie Inc.
    • 13.1.3. AstraZeneca PLC
    • 13.1.4. Boehringer Ingelheim International GmbH
    • 13.1.5. Cadila Healthcare Ltd.
    • 13.1.6. Century Pharmaceuticals Ltd.
    • 13.1.7. Daewoong Pharmaceutical Co. LTD.
    • 13.1.8. Dr. Reddy's Laboratories Ltd
    • 13.1.9. Eisai Co. Ltd.
    • 13.1.10. F. Hoffmann-La Roche Ltd.
    • 13.1.11. GlaxoSmithKline PLC
    • 13.1.12. Hikma Pharmaceuticals PLC
    • 13.1.13. Medopharm Pvt Ltd
    • 13.1.14. Merck KGaA
    • 13.1.15. Mylan N.V.
    • 13.1.16. Novartis AG
    • 13.1.17. Pfizer Inc.
    • 13.1.18. Pharmanova India Drugs Pvt. Ltd.
    • 13.1.19. Redhill Biopharma Ltd
    • 13.1.20. Rosemont Pharmaceuticals Limited
    • 13.1.21. Takeda Pharmaceutical Company Limited
    • 13.1.22. Teva Pharmaceutical Industries Ltd.
    • 13.1.23. Ulcerex Pharma
    • 13.1.24. USAntibiotics
    • 13.1.25. Yuhan Corporation
  • 13.2. Key Product Portfolio

14. Appendix

  • 14.1. Discussion Guide
  • 14.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. PEPTIC ULCER DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. PEPTIC ULCER DRUGS MARKET SIZE, 2022 VS 2030
  • FIGURE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2022 VS 2030 (%)
  • FIGURE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 6. PEPTIC ULCER DRUGS MARKET DYNAMICS
  • FIGURE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2022 VS 2030 (%)
  • FIGURE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2030 (%)
  • FIGURE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2030 (%)
  • FIGURE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 14. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2022 VS 2030 (%)
  • FIGURE 16. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2022 VS 2023 VS 2030 (USD MILLION)
  • FIGURE 21. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • FIGURE 22. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2022

LIST OF TABLES

  • TABLE 1. PEPTIC ULCER DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2022
  • TABLE 3. PEPTIC ULCER DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL PEPTIC ULCER DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. PEPTIC ULCER DRUGS MARKET SIZE, BY DUODENAL ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. PEPTIC ULCER DRUGS MARKET SIZE, BY GASTRIC ULCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 9. PEPTIC ULCER DRUGS MARKET SIZE, BY CYTOPROTECTIVE AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. PEPTIC ULCER DRUGS MARKET SIZE, BY H2 BLOCKERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. PEPTIC ULCER DRUGS MARKET SIZE, BY PROTON PUMP INHIBITORS (PPIS), BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 13. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 15. PEPTIC ULCER DRUGS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. PEPTIC ULCER DRUGS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. PEPTIC ULCER DRUGS MARKET SIZE, BY ONLINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 26. ARGENTINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 30. BRAZIL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 34. CANADA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 35. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 38. MEXICO PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 39. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 40. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 42. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 43. UNITED STATES PEPTIC ULCER DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 44. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 47. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 48. ASIA-PACIFIC PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 49. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 50. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 52. AUSTRALIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 53. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 56. CHINA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 57. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 60. INDIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 61. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 63. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 64. INDONESIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 65. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 68. JAPAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 69. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 72. MALAYSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 73. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 76. PHILIPPINES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 77. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 80. SINGAPORE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 81. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH KOREA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 85. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 88. TAIWAN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 89. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 92. THAILAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 93. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 96. VIETNAM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 97. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 100. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 101. EUROPE, MIDDLE EAST & AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 102. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 105. DENMARK PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 106. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 107. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 109. EGYPT PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 110. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 112. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 113. FINLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 114. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 117. FRANCE PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 118. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 121. GERMANY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 122. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 125. ISRAEL PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 126. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 127. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 129. ITALY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 130. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 132. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 133. NETHERLANDS PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 134. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 137. NIGERIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 138. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 141. NORWAY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 142. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 143. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 145. POLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 146. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 148. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 149. QATAR PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 150. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 153. RUSSIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 154. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 157. SAUDI ARABIA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 158. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 161. SOUTH AFRICA PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 162. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 163. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 165. SPAIN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 166. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 169. SWEDEN PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 170. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 173. SWITZERLAND PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 174. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 177. TURKEY PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 178. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 181. UNITED ARAB EMIRATES PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 182. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY PEPTIC ULCER TYPE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED KINGDOM PEPTIC ULCER DRUGS MARKET SIZE, BY OFFLINE, 2018-2030 (USD MILLION)
  • TABLE 186. PEPTIC ULCER DRUGS MARKET, FPNV POSITIONING MATRIX, 2022
  • TABLE 187. PEPTIC ULCER DRUGS MARKET SHARE, BY KEY PLAYER, 2022
  • TABLE 188. PEPTIC ULCER DRUGS MARKET LICENSE & PRICING